The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

MVA-BN is indicated for active immunization against smallpox, mpox, and related orthopoxvirus infections and disease in all adults 18 years of age and older. According to recommendations from the ...

The MVA-BN vaccine, designed for smallpox, has shown 58% effectiveness against mpox after a single dose in a Canadian study. This finding is significant for controlling the virus's spread among ...

The mpox vaccine currently in use in Indonesia is the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), a third-generation non-replicating smallpox-derived vaccine. Mpox vaccinations using the ...

The mpox vaccine currently in use in Indonesia is the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), a third-generation non-replicating smallpox-derived vaccine. Mpox vaccinations using the MVA-BN ...

Mpox vaccine MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, are offloaded from a plane in Kinshasa, Congo, Thursday, Sept. 5, 2024. Credit: AP/Samy Ntumba Shambuyi The number ...